Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
CAS 13583-21-6
Concern score
Also known as 4-Chloro-17beta-hydroxyestr-4-en-3-one · 4-CHLORO-17.BETA.-HYDROXYESTR-4-EN-3-ONE · ANABOL-4-19 · DEA No. 4000 · Estr-4-en-3-one, 4-chloro-17-hydroxy-, (17beta)- · Lentabol
Norclostebol (1.0 mg/mL in Acetonitrile) · Norclostebolum · Q7050483 · UNII-VI1001O2DI
We don't have a plain-language description for Norclostebol yet.
Recorded functional uses: Pharmaceutical
No restrictions found. Norclostebol appears in these published regulatory listings.
No graded research studies for Norclostebol yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
How often EPA CPDat has listed Norclostebol in a product composition. These are source records, not Greenveil catalog products.
Named organisations
2
Typical roles